Dr. Susan Marshall, MD

Dr. Marshall practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Marshall's NPI, 1861653578, was assigned on June 24, 2008. Dr. Marshall graduated from Renaissance School of Medicine at Stony Brook University in 2008. Dr. Marshall holds New York license 269406.

Dr. Marshall's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Marshall also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Marshall's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Marshall to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marshall practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Marshall's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Marshall is board certified in urology by the American Board of Urology. Dr. Marshall is licensed in New York.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney stone disease, prostate cancer, urinary endoscopy and urine flow blockage among the conditions Dr. Marshall treats.

CMS data shows 644 Medicare services from Dr. Marshall across 11 procedure codes in 2024, for 170 Medicare patients. Medicare paid $58,128 for them. Every service was in an office.

CMS counts 170 Medicare patients who saw Dr. Marshall in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Marshall's median patient age at 59, with 45% women.

In 2024, Dr. Marshall wrote 463 Medicare Part D claims for 191 patients. 94% of them were for generic drugs. CMS names the drug for 367 of them, across 11 drugs with 11 or more claims each, at $13,722 in total drug cost. In 2023, CMS named 1,007 claims across 20 drugs.

Dr. Marshall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marshall as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Marshall, published from 2012 to 2022. 2014 was the busiest year, with 2. The most frequent topics are Kidney Neoplasms, Nephrectomy and Carcinoma, Renal Cell. Dr. Marshall has published most often in J Endourol. Dr. Marshall's most frequent co-authors are Mohamad E. Allaf, MD, Mark Wayne Ball, MD and Sam B. Bhayani, MD.

CMS Open Payments shows 27 general payments to Dr. Marshall from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Astellas Pharma US Inc paid the most, $123.

Dmand AI lists 1 award for Dr. Marshall, most recently CMS Stage 1 EHR in 2013.

Dr. Marshall graduated from Renaissance School of Medicine at Stony Brook University in 2008.

Dr. Marshall is in network with 17 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.